DOOR framework shows similar outcomes in skin infection trials - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

DOOR framework shows similar outcomes in skin infection trials

“Using DOOR can provide clinicians and patients with a better understanding of the benefits and risks of new anti-infectives being studied to treat skin infections.” 

  • By

  • Matthew Solan

  • August 24, 2026

  • 7 min

Share

Original Source(s)

DOOR framework shows similar outcomes in skin infection trials

  • by Matthew Solan

  • August 24, 2026

Related Content

CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria

Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms

  • April 2, 2026

  • 2 min
IDSA updates guidance for antimicrobial-resistant gram-negative infections

"Determining how best to place and use these agents requires weighing multiple factors and is a constantly evolving science."

The 18-Month MDR-TB Regimen Has a Successor

Six months, all-oral, better tolerated—and the infrastructure to make it work.